Policy Briefings

Sai Life Sciences Completes Phase II of Production Block 11 in Bidar

George Medicines and Piramal Pharma Solutions Launch WIDAPLIK

Altasciences Partners with Evidence Matters to Enhance Regulatory Writing with AI

Asymchem Expands Flow Chemistry Capabilities at UK Facility

Daewoong Bio Opens Bio-Center in Hyangnam to Deliver End-to-End CMO Services

Hongene Biotech Signs Licensing Deal with UMass Chan for exNA Technology

Boehringer Ingelheim Signs CDMO Agreement with AnGes for HGF Gene Therapy

Cambrex Enhances Peptide Capabilities with Waltham Facility Expansion

AAHI partners with Quratis as preferred CDMO for vaccine manufacturing

ProMed Pharma Expands CDMO Capabilities with Plymouth Facility Acquisition

Laurus Labs to Merge LSPL into Parent Company in Major Restructuring

Andelyn Biosciences Partners with Amplo Biotechnology to Scale AAV Gene Therapy Production

Piramal Pharma Solutions and NewAmsterdam Pharma Invest in Dedicated Suite to Enhance Oral Solid Dosage Capabilities

Johnson & Johnson Increases U.S. Manufacturing Capacity at FUJIFILM’s Holly Springs Facility

Catalent Reduces Workforce in Gene Therapy Manufacturing by 350 Employees

ChemPartner Opens Boston Center of Excellence to Expand U.S. CDMO and CRO Services

Nucleus RadioPharma Appoints Dr. Stephen M. Hahn as CEO

WuXi Biologics Reports RMB9.95 Billion H1 2025 Revenue, Up 16%